Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Glioma × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

Phase

Status

Completed 3 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Glioblastoma 3 Carcinoma, Non-Small-Cell Lung 3 Osteosarcoma 2 Neuroblastoma 2 Lymphoma 2 Leukemia 2 Xanthomatosis, Cerebrotendinous 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Tetanus 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Kidney Neoplasms 1 Influenza, Human 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Colonic Neoplasms 1

Interventions

Temozolomide 21 Bevacizumab 10 Radiotherapy 5 Irinotecan 5 Carmustine 4 Topotecan 3 Magnetic Resonance Spectroscopy 3 Magnetic Resonance Imaging 3 Carboplatin 3 Aminolevulinic Acid 3 ribociclib 2 poly ICLC 2 fluoromisonidazole 2 fluorodopa F 18 2 carmustine, poliferprosan 20 drug combination 2 cabozantinib 2 TIC10 compound 2 Surgical Procedures, Operative 2 Standard of Care 2 Re-Irradiation 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Panobinostat 2 O(6)-benzylguanine 2 Melphalan 2 Lomustine 2 Lacosamide 2 Filgrastim 2 Erlotinib Hydrochloride 2 Dynamic Contrast Enhanced Magnetic Resonance Imaging 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03334305 2026-01-29

ACTION

University of Florida

Phase 1 Terminated

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡